TLR9 and neoplasm: However, we found that the proportion of CD8+ T cells were significantly decreased despite of increase of DC and CD4+ T cells in tumor after TLR9 agonist stimulation (Figure S4C), suggesting that TLR9 agonist may induce immune escape by inhibiting T cell infiltration and activation in tumor microenvironment.